ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1511	National Cancer Institute	Html	en	Small Cell Lung Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of small cell lung cancer.	clinical trial 0.236127 treatment 0.276669 patients 0.200061 Lung Cancer Prevention 0.201183 cancer cells 0.289303 body 0.206914 Lung Cancer Treatment 0.223408	PDQ cancer information 0.202281 cell lung cancer 0.911961 small cell lung 0.946074 radiation therapy 0.266516 National Cancer Institute 0.212636 clinical trials 0.458637 information 0.20384	CLICK HERE
1518	National Cancer Institute	Html	en	Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult non-Hodgkin lymphoma.	indolent lymphoma 0.464365 treatment 0.544599 monocytoid B-cell lymphoma 0.420859 plasmablastic lymphoma 0.419927 NK -/T-cell lymphoma 0.426757 small lymphocytic lymphoma 0.423228 gastric malt lymphoma 0.422838 Immunodeficiency-related Burkitt lymphoma 0.415337 aggressive non-Hodgkin lymphoma 0.475259 cutaneous T-cell lymphoma 0.428401 panniculitis-like T-cell lymphoma 0.426066 Non-Hodgkin Lymphoma section 0.42959 extranodal nk-/t-cell lymphoma 0.422171 intestinal T-cell lymphoma 0.425153 cancer cells 0.415937 burkitt lymphoma 0.478875 type 0.432175 Childhood Non-Hodgkin Lymphoma 0.486001 Non-Hodgkin Lymphoma Treatment 0.517724 non-Hodgkin lymphoma depend 0.431176 B-cell non-Hodgkin lymphoma 0.483095 adult non-hodgkin lymphoma 0.682631 Hepatosplenic T-cell lymphoma 0.418177 mantle cell lymphoma 0.469654	clinical trials 0.431842 large cell lymphoma 0.519814 peripheral t-cell lymphoma 0.449001 lymphoblastic lymphoma 0.466951 sporadic Burkitt lymphoma 0.415034 follicular lymphoma 0.466223 lymphoplasmacytic lymphoma 0.484976 anaplastic lymphoma kinase 0.415433 zone lymphoma forms 0.432298 extragastric malt lymphoma 0.451025 non-hodgkin lymphoma 0.940013 bone marrow 0.479363 Mediterranean abdominal lymphoma 0.426917 marginal zone lymphoma 0.520209 aggressive lymphoma 0.473801 lymphoma cells 0.457101 Angioimmunoblastic T-cell lymphoma 0.41858 lymph nodes 0.489794 large B-cell lymphoma 0.570397 radiation therapy 0.436362 anaplastic large cell 0.422021 cancer 0.555203 indolent non-hodgkin lymphoma 0.488068	CLICK HERE
1706	National Cancer Institute	Html	en	Tumor Markers	A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.	average risk 0.450619 Urokinase plasminogen activator 0.459684 EGFR gene mutation 0.458827 low recurrence rates 0.462003 potential markers 0.487538 tumor marker 0.811954 Laboratory Improvement Amendments 0.454191 Cancer researchers 0.453927 tumor tissue 0.581622 prostate cancer deaths 0.482408 cancer cells 0.464646 randomized controlled trials 0.451211 cancer therapy 0.462023 Programmed death ligand 0.453669 certain tumor markers 0.637279 Tumor marker levels 0.59758 tumor cells 0.533609 hormone therapy 0.468386 plasminogen activator inhibitor 0.458435 Ovarian Cancer Screening 0.481982 oncotype dx® 0.458204 NCI-sponsored Trial Assigning 0.453214 cancer care 0.460826 European Randomized Study 0.452179	benign prostate conditions 0.461678 BRAF V600 mutations 0.455095 tumor markers 0.944185 ovarian cancer 0.509174 gene mutation 0.459648 Diagnosis research page 0.451878 cancer types 0.497466 BCR-ABL fusion gene 0.458705 follow-up diagnostic tests 0.453464 Beta-human chorionic gonadotropin 0.457581 prostate cancer 0.504684 KRAS gene mutation 0.459458 elevated PSA level 0.472298 ALK gene rearrangements 0.462612 cancer staging 0.458494 accurate tumor markers 0.611174 cancer recurrence 0.463465 different tumor markers 0.654628 HER2-negative breast cancer 0.476048 noncancerous) conditions. 0.470899 cancer 0.625548 Nuclear matrix protein 0.450815 gene expression 0.46063	CLICK HERE
1778	National Cancer Institute	Html	es	Delirium (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del delirium como una complicación del cáncer o su tratamiento. Se discuten los abordajes de los cuidados médicos de apoyo, así como farmacológicos para el manejo del delirium.	delirium rating 0.635037 Cancer Res Clin 0.330668 Breitbart W 0.391378 recognizing delirium 0.408363 Misdiagnosing delirium 0.408657 Sin embargo 0.38098 delirium among elderly 0.415971 Fainsinger RL 0.329645 Lipowski ZJ 0.334677 Gagnon B 0.354723 Predicting delirium 0.41556 risk factors 0.327409 Delirium Assessment Scale 0.517982 Delirium risk 0.412345 Delirium presenting with 0.419293 patients with delirium 0.445355 Natl Cancer Inst 0.328774 antipsicóticos típicos 0.342502 McCallion J 0.33665 Lawlor PG 0.511955 término delirium 0.437321 Neuropsychiatry Clin Neurosci 0.328992 Mancini IL 0.351836 hospitalized patients with 0.376004 específica cuáles pacientes 0.32777	Palliat Care 0.338189 patients with 0.960984 Pain Symptom Manage 0.86069 prevent delirium 0.429024 Miller L 0.327272 American Psychiatric Association 0.3525 bedside confusion scale 0.336758 Care Cancer 0.332558 palliative care 0.358676 hospitalized elderly 0.35987 Memorial Delirium Assessment 0.513933 Delirium after 0.413891 Intern Med 0.666809 delirium rating scale-revised-98 0.51332 confusion assessment method 0.339276 Clin Oncol 0.334335 Arch Intern Med 0.574627 Bruera E 0.37373 with adjuvant 0.332147 elderly patient 0.402747 terminal delirium 0.422735 antipsicóticos atípicos 0.439946 prospective study 0.581043 Inouye SK 0.47182	CLICK HERE
2024	National Cancer Institute	Html	es	Exámenes de detección del cáncer de seno (mama) (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre exámenes que se usan para detectar el cáncer de mama.	siguientes grupos 0.672278 antecedentes familiares 0.758929 riesgo promedio 0.654596 mamas ayuda 0.659647 siguientes aspectos 0.90581 PDQ Exámenes 0.70298 científicos estudian 0.803132 Physician Data Query 0.762154 Estados Unidos 0.676822 Cuánto dolor 0.645226 siguientes características 0.695745 rayos x 0.663809	prevención revisa 0.628149 PDQ Prevención 0.818992 presente síntomas 0.647624 información ayuda 0.645226 National Cancer Institute 0.638447 mamografía dé 0.72651 siguientes riesgos 0.642827 PDQ Aspectos 0.696695 genes brca1 0.6651 siguientes sumarios 0.787128 Instituto Nacional 0.674216	CLICK HERE
2046	National Cancer Institute	Html	es	Exámenes de detección del cáncer de ovario, de trompas de Falopio y primario de peritoneo (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de ovario, de trompas de Falopio y primario de peritoneo.	sumario prevención 0.472534 Visuals Online 0.345966 PDQ Exámenes 0.447043 Physician Data Query 0.632388 Gynecologic Cancers 0.420191 Estados Unidos 0.412228 cuello uterino 0.924963 prevención revisa 0.358425 principal causa 0.399054	uso conjunto 0.372607 información ayuda 0.370212 Características genéticas 0.409802 National Cancer Institute 0.381425 ecografía transvaginal 0.909246 siguientes riesgos 0.361332 siguientes sumarios 0.506181 Instituto Nacional 0.45524	CLICK HERE
3459	National Cancer Institute	Html	es	Coenzima Q10 (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la conzima Q10 como tratamiento para las personas con cáncer.	Centro Nacional 0.333125 Vitamina Q10 0.341732 New Hampshire Avenue 0.323053 Drug Administration 0.314317 leucemia linfoblástica aguda 0.341078 NCI Best Case 0.342133 vía oral 0.324149 mejores pruebas 0.318969 datos bibliográficos pubmed 0.324983 siguientes preguntas 0.314202 mayores cantidades 0.322901 Premio Nobel 0.323381 siguientes riesgos 0.318032 máximo nivel 0.322444 seguro médico 0.313926 Instituto Nacional 0.428917 vitamina e 0.322593 conzima q10 0.331342 Salud Complementaria 0.35167	Visuals Online 0.317138 complementarias revisa 0.324022 daños causados​por 0.322061 Physician Data Query 0.399292 coenzima q10 0.631002 Estados Unidos 0.532938 cáncer doxorrubicina 0.420236 antraciclina doxorrubicina 0.326213 libre uso 0.31803 página manejo 0.315983 ¿El tratamiento 0.336183 ¿Los beneficios 0.314951 CoQ10 ayuda 0.788819 cuerpo elabora 0.394571 coenzima ayuda 0.33485 Series Program 0.314402 medicina complementaria 0.970585 siguientes deficiencias 0.324091	CLICK HERE
3856	National Cancer Institute	Html	en	Christal Sohl, Ph.D.	The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer.	personal time 0.583145 polymerase enzymes 0.576932 isocitrate dehydrogenase 0.57565 environmental pollutants 0.576985 Fred Guengerich 0.587519 cell growth 0.572096 K99/R00 grant application 0.63899 job applications 0.56948 generous people 0.568794 enzyme structure 0.620541 mutated conditions 0.575037 cancer-promoting metabolite 0.574359 Diego State University 0.633881 graduate school 0.57248 single point mutation 0.637959 research career 0.583765 strong mentoring relationships 0.632479 biological substrate 0.582981 daunting prospect 0.569185 enzyme functions 0.618027 Dr. Guengerich 0.599167 tumor-suppressing effects 0.571078 brand-new assistant professor 0.63038 clinically relevant problem 0.636226 research goal 0.576225	SDSU students 0.573824 postdoc Dr 0.580928 kinases—cellular signaling proteins 0.631824 Vanderbilt University 0.576153 cancer drugs 0.568875 R01 grant 0.59259 human disease 0.573514 K99/R00 grant 0.703102 George Richter-Addo 0.576773 undergraduate biochemistry course 0.648526 Yale University 0.573003 enzyme kinetics—the study 0.706771 earlier career stages 0.620329 enzymatic reaction 0.574931 inaccurate DNA replication 0.627233 assistant professor 0.762524 Karen Anderson 0.570977 K99/R00 transition grant 0.643727 Dr. Sohl 0.961111 hard work 0.580209 enzyme kinetics—and 0.636377 single step 0.57426 DNA strands 0.56849 Christal Sohl 0.703616	CLICK HERE
4329	National Cancer Institute	Html	en	Cancer Screening	A summary of the benefits and possible harms of cancer screening tests.	time symptoms 0.320649 abnormal tissue 0.346264 False-negative test results 0.440391 screening tests 0.953871 false reassurance 0.328265 potential harms 0.743558 different cancer screening 0.573019 medical care 0.312433	people 0.200595 Early detection 0.319119 additional tests 0.299571 health problems 0.324983 doctors 0.208104 False-positive test results 0.450006 cancer 0.861445	CLICK HERE
15671	National Cancer Institute	Html	en	National Cancer Institute Overview and Mission	Learn about the National Cancer Institute and what we do, our impact, and our future plans.	NCI Budget Fact 0.497121 federally funded research 0.465442 research education 0.373076 cancer deaths 0.368559 research efforts 0.378749 clinical trial sites 0.42553 improved cancer treatments 0.481082 new cancer cases 0.455562 private-sector life sciences 0.407381 research career development 0.478109 clinical trials 0.413733 publicly available cancer 0.474225 National Institutes 0.330098 cancer patients 0.381628 research laboratories 0.378804 comprehensive training programs 0.420146 NCI 0.551669 clinical research 0.391338 cancer survivors 0.364801 training opportunities 0.416201 intramural training programs 0.437578 National Cancer Program 0.503712 career development opportunities 0.414542 Funds training 0.333548 advanced technology development 0.398899	Maintains long-term storage 0.390918 cancer prevention 0.393108 United States 0.478805 training grants 0.329153 cancer research 0.942525 private philanthropic organizations 0.403666 scientific knowledge 0.423431 cancer research disciplines 0.531444 various research programs 0.452562 National Cancer Institute 0.528313 NCI laboratories 0.431835 cancer researchers 0.38535 research institutions 0.37224 Supports intramural research 0.523044 innovative laboratory research 0.451762 Frederick National Laboratory 0.407026 cancer detection 0.370327 NCI’s expenditures 0.416543 career development 0.479695 cancer care delivery 0.459112 biomedical research 0.373736 cancer research enterprise 0.566317 NCI’s laboratories 0.427372 NCI-Designated Cancer Centers 0.493446	CLICK HERE